SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 137 filers reported holding SUTRO BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is 0.60 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,337,672 | -29.5% | 1,538,234 | -5.5% | 0.04% | -30.9% |
| Q2 2023 | $7,571,288 | -4.3% | 1,628,234 | -12.5% | 0.06% | 0.0% |
| Q1 2023 | $7,912,755 | +24.1% | 1,860,775 | +135.8% | 0.06% | +27.9% |
| Q4 2022 | $6,376,308 | -36.1% | 789,184 | -56.1% | 0.04% | -38.6% |
| Q3 2022 | $9,984,000 | +2962.6% | 1,798,838 | +2772.9% | 0.07% | +2233.3% |
| Q2 2022 | $326,000 | -95.2% | 62,613 | -82.9% | 0.00% | -93.6% |
| Q2 2021 | $6,807,000 | -11.3% | 366,207 | -0.5% | 0.05% | -26.6% |
| Q1 2021 | $7,677,000 | -3.9% | 368,110 | -0.0% | 0.06% | +1.6% |
| Q4 2020 | $7,992,000 | – | 368,114 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $39,611,000 | 19.08% |
| Samsara BioCapital, LLC | 1,675,579 | $36,377,000 | 3.66% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 185,000 | $4,016,000 | 2.33% |
| Affinity Asset Advisors, LLC | 200,000 | $4,342,000 | 2.30% |
| Altium Capital Management LP | 276,719 | $6,008,000 | 2.24% |
| FRAZIER MANAGEMENT LLC | 1,001,421 | $21,741,000 | 1.67% |
| BVF INC/IL | 1,854,162 | $40,254,000 | 1.58% |
| Asymmetry Capital Management, L.P. | 157,583 | $3,421,000 | 1.56% |
| Parkman Healthcare Partners LLC | 266,645 | $5,789,000 | 1.48% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,799,000 | 1.44% |